Oliveira, Erica Aparecida de; Fernandes, Débora Kristina Alves; Flores, Fernanda Faião; Lima, Diógenes Saulo de; Cardozo, Lucas Esteves; Nakaya, Helder Takashi Imoto 
; Maria-Engler, Silvya Stuchi
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de et al. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 out. 2024. , 2017APA
Oliveira, E. A. de, Fernandes, D. K. A., Flores, F. F., Lima, D. S. de, Cardozo, L. E., Nakaya, H. T. I., & Maria-Engler, S. S. (2017). Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2024 out. 01 ]Vancouver
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2024 out. 01 ]
